Hormonal Action: By acting on the hypothalamus, the part of the brain that controls hunger, GLP-1 medications help reduce food cravings and binge eating behaviors
Once the sequence was known and recombinant expression became routine, native-sequence human IGF-1 became available as a laboratory reagent and, separately, as a licensed protein under the name mecasermin
Symptoms include abdominal pain, upset stomach, fever and weight loss
The researchers, experts in heart health, concluded that GLP-1 weight-loss drugs could offer a promising new therapeutic approach for improving heart attack recovery
Reconstitution at a Glance The most common research-protocol approach for a 30mg vial: add 3.0mL bacteriostatic water to produce a 10mg/mL working concentration